Inventor
PASSINI MARCO A
US25 patents
⚠️ This page may combine multiple inventors who share the name “PASSINI MARCO A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENZYME CORP
10 patentsUS10369193B2Aug 6, 2019
Gene therapy for neurodegenerative disorders
GENZYME CORP17 citations94
US9415119B2Aug 16, 2016
Gene therapy for neurodegenerative disorders
GENZYME CORP13 citations92
US11911440B2Feb 27, 2024
Gene therapy for neurodegenerative disorders
GENZYME CORP5 citations86
US10080783B2Sep 25, 2018
Intraventricular enzyme delivery for lysosomal storage diseases
GENZYME CORP6 citations84
US10821154B2Nov 3, 2020
Compositions and methods for treating spinal muscular atrophy
GENZYME CORP7 citations82
US11975043B2May 7, 2024
Gene therapy for neurodegenerative disorders
GENZYME CORP3 citations75
US11253485B2Feb 22, 2022
Slow intraventricular delivery
GENZYME CORP4 citations68
US12350311B2Jul 8, 2025
Gene therapy for neurodegenerative disorders
GENZYME CORP0 citations62
US11957765B2Apr 16, 2024
Gene therapy for neurometabolic disorders
GENZYME CORP1 citations62
US10913956B2Feb 9, 2021
Gene therapy for neurometabolic disorders
GENZYME CORP0 citations47
SAREPTA THERAPEUTICS INC
10 patentsUS11000600B2May 11, 2021
Exon skipping oligomer conjugates for muscular dystrophy
SAREPTA THERAPEUTICS INC6 citations84
US10888578B2Jan 12, 2021
Exon skipping oligomer conjugates for muscular dystrophy
SAREPTA THERAPEUTICS INC6 citations84
US11382981B2Jul 12, 2022
Exon skipping oligomer conjugates for muscular dystrophy
SAREPTA THERAPEUTICS INC3 citations73
US11338041B2May 24, 2022
Exon skipping oligomer conjugates for muscular dystrophy
SAREPTA THERAPEUTICS INC1 citations71
US10765760B2Sep 8, 2020
Exon skipping oligomer conjugates for muscular dystrophy
SAREPTA THERAPEUTICS INC1 citations71
US12377150B2Aug 5, 2025
Exon skipping oligomer conjugates for muscular dystrophy
SAREPTA THERAPEUTICS INC0 citations62
US12121532B2Oct 22, 2024
Modified antisense oligomers for exon inclusion in spinal muscular atrophy
SAREPTA THERAPEUTICS INC0 citations62
US11642364B2May 9, 2023
Exon skipping oligomer conjugates for muscular dystrophy
SAREPTA THERAPEUTICS INC0 citations62
US11395855B2Jul 26, 2022
Exon skipping oligomer conjugates for muscular dystrophy
SAREPTA THERAPEUTICS INC1 citations62
US10905709B2Feb 2, 2021
Modified antisense oligomers for exon inclusion in spinal muscular atrophy
SAREPTA THERAPEUTICS INC1 citations62